// App-Quantinova.ai

2105M-11 : FINAL FIVE-YEAR FOLLOW-UP OF POLYMER-FREE SIROLIMUS- AND PROBUCOL-ELUTING STENTS VERSUS NEW GENERATION ZOTAROLIMUS-ELUTING STENTS IN PATIENTS WITH CORONARY ARTERY DISEASE

Researchers

Presenter

  • Robert A. Byrne

Principal Investigators

  • Sebastian Kufner

  • Jonas Sorges

  • Janika Repp

  • Salvatore Cassese

  • Stefanie Schulz

  • Massimiliano Fusaro

  • Ilka Ott

  • Tareq Ibrahim

  • Karl-Ludwig Laugwitz

  • Adnan Kastrati

Medical Centers

  • Medizinische Klinik, Klinkum rects der Isar, Munich, Germany

  • Deutsches Herzzentrum Munchen, Munich, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Coronary Artery Disease

  • Myocardial infarction

  • Venous thrombosis

  • Diabetes

Biomarkers

  • Acetyl-CoA carboxylase

Drug/Treatment

  • ZoMaxx

  • Rapacan

  • Probucol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved